Publication
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo
Alessandro Antonelli, Guido Bocci, Concettina La Motta, Silvia Martina Ferrari, Poupak Fallahi, Alda Corrado, Anna Fioravanti, Stefania Sartini, Paola Orlandi, Simona Piaggi, Alessandro Corti, Gabriele Materazzi, David Galleri, Salvatore Ulisse, Gabriella Fontanini, Romano Danesi, Federico Da Settimo, Paolo Miccoli
Molecular and Cellular Endocrinology, August 2014, Elsevier
DOI: 10.1016/j.mce.2014.06.002